Althea is proud to announce that it is set to become the first commercial supplier of Australian made medicinal cannabis extract products to be sold and distributed in the…
read more
Investment Highlights Althea’s wholly-owned subsidiary Peak Processing Solutions will immediately commence commercial operations having successfully obtained its…
read moreInvestment Highlights Patients purchasing products online through Althea Concierge™ have helped the company set a new Australian patient and revenue record in July…
read moreAlthea CEO Joshua Fegan provides the team at Ausbiz with an update on some of the latest achievements at Althea including an in depth update on the latest functionality of…
read moreAlthea is dedicated to supporting healthcare providers seeking information about and access to medicinal cannabis as a treatment option for eligible patients. One of the ways we connect with healthcare providers is by attending conferences and arranging education events.
View More Events
The growth continues! Althea has officially reached over 5,000 patients. This is an exciting milestone and a great reflection of the relentless hard work from all of the team. Thank you to all our fantastic partners and we look forward to further continued growth in 2020. https://t.co/itYfbPQHZn
read moreOur CEO Josh Fegan sat down with @CommSec's Tom Piotrowski to discuss our focus on education & technology to improve patient access to medicinal cannabis & the positive regulatory outlook for new jurisdictions & emerging markets | Video: http://ow.ly/BTEj50v0x8C
read moreAlthea is thrilled to announce that we will supply the first UK national medical cannabis pilot targeting 20,000 patients | Read the ASX announcement here: https://www.asx.com.au/asxpdf/20190625/pdf/4462xcgx974f62.pdf $AGH
read more
©2020 Althea Company Pty Ltd
